Your browser doesn't support javascript.
loading
Clinical Pharmacology in Drug Development for Rare Diseases in Neurology: Contributions and Opportunities.
Abuasal, Bilal; Ahmed, Mariam A; Patel, Priyank; Albusaysi, Salwa; Sabarinath, Sreedharan; Uppoor, Ramana; Mehta, Mehul.
Affiliation
  • Abuasal B; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Ahmed MA; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Patel P; Takeda Pharmaceutical US, Cambridge, Massachusetts, USA.
  • Albusaysi S; School of Pharmacy, University of Maryland, Baltimore, Maryland, USA.
  • Sabarinath S; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Uppoor R; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Mehta M; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Clin Pharmacol Ther ; 111(4): 786-798, 2022 04.
Article in En | MEDLINE | ID: mdl-34860361
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacology, Clinical / Nervous System Diseases / Neurology Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacology, Clinical / Nervous System Diseases / Neurology Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States